GP-RTA (Retatrutide) (Vial)

GP-RTA (Retatrutide) – Research Peptide Vial

Retatrutide is a synthetic peptide being studied as a triple agonist of the GLP-1, GIP and glucagon receptors. It is an investigational compound and is studied in laboratory research on metabolic signalling.

Product details:

• Available strengths: 10 mg or 20 mg per vial

• Form: Lyophilised (freeze-dried) powder

• Purity: 99%

• Sealed vial with rubber stopper and flip-off cap

• Third-party lab tested (COA available on request)

• Reconstitute with bacteriostatic water (sold separately)

Storage: Store unopened vials in a refrigerator (2–8°C), or frozen for long-term storage, away from light. Once reconstituted, keep refrigerated.

Disclaimer: For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated by the FDA.